– Over 40 Years in Investment Banking – Extensive Regulatory and Securities Advisory Experience BOCA RATON, Fla., Aug. 2, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today announced the appointment of Anthony […]
Blog
New Procedure Spares Skin Cancer Patients From Surgery
Colorado’s Attorney General Cynthia Coffman became among the first in the state to undergo treatment with the SRT-100™. Doctor Kevin Schewe at Red Rocks Radiation Center, in partnership with Presbyterian/St. Luke’s Medical Center and Sarah Cannon Research Institute, is the only one in Colorado offering Superficial Radio Therapy with the SRT-100™ for patients with non-melanoma […]
Sensus Healthcare, Inc. Units Separate; Trading of Common Stock and Warrants Commences
BOCA RATON, Fla., July 25, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTSU), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today reported the separation of the 2,300,000 units issued in its underwritten initial public offering in accordance with their terms. […]
Sensus Healthcare, Inc. Announces Separation of Units Sold in IPO
BOCA RATON, Fla., July 21, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTSU), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today announced that the 2,300,000 units issued in its underwritten initial public offering will separate in accordance with their terms […]
The SRT-100™ Beats The Keloid Scar
A quick question for you–what do you tell your patients when they come into your office and inform you that they have a keloid scar they want to get rid of? Do you offer a surgical solution that will result in them going under the knife and being stitched up? If your patient is aichmophobic, […]
SRT – The Best Keloid Scar Treatment!
SRT is the best keloid scar treatment on the market. Keloids form after the skin has been injured and the growth of fibrous tissue, more commonly known as scar tissue, begins to grow excessively. These unsightly, smooth, yet hard colonies of scar tissue are found mostly on the shoulders, cheeks, earlobes, and chest but can […]
Keloid Management: A Retrospective Case Review on a New Approach Using Surgical Excision, Platelet-Rich Plasma, and In-office Superficial Photon X-ray Radiotherapy
Michael E. Jones; Cherrell Hardy, BSN, RN; and Julie Ridgway, BSN, RN Jones Keloids Paper – July 2016 Advances in Skin & Wound Care
Provide Your Patients with an Alternative to Mohs Surgery: The SRT-100™
As a form of treatment for basal cell carcinoma and squamous cell carcinoma, Mohs surgery has lead the forefront of surgery options for decades. You may prefer Mohs surgery rather than other forms of surgery because of its precision due to its microscopic nature. However, there are no procedures without their drawbacks. You can’t put […]
Looking for an Alternative to Mohs Surgery? Look No Further than the SRT-100™
Each year millions of Americans are diagnosed with some form of squamous cell carcinoma or basal cell carcinoma. Naturally, this forces those affected to seek out forms of treatment to get rid of the cancerous cells, which are located on the outer layer of the skin. One of those types of treatments is Mohs surgery. […]
Sensus Healthcare Rings the Opening Bell at the Nasdaq MarketSite
Sensus Healthcare participated in an opening bell ringing ceremony at the Nasdaq MarketSite on Thursday, June 9, 2016. With important employees, partners and families on hand, Sensus Healthcare’s Chief Executive Officer, Joseph Sardano, officially opened the trading day on Nasdaq. This ceremony comes on the heels of the successful Initial Public Offering (IPO) of Sensus […]
Sensus Healthcare, Inc. Announces Completion of Initial Public Offering, including Underwriters’ Exercise of Over-Allotment Option in Full
BOCA RATON, Fla., June 8, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTSU), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today announced the completion of its initial public offering of 2,300,000 units at a public offering price of $5.50 per […]
ASDS: Skin Cancer Treatments Among Most Frequently Performed Procedures in 2015
Dermatologic surgeons performed nearly 10 million medical and cosmetic procedures in 2015 – up five percent since 2014 and 27 percent since 2012, according to the 2015 American Society for Dermatologic Surgery (ASDS) Survey on Dermatologic Procedures. For the fourth year in a row, skin cancer treatments ranked as the most-performed procedure (3.17 million) by ASDS members. […]
Non-Surgical Skin Cancer Treatment for You: The SRT-100™ to the Rescue
Unfortunately, skin cancer is the most common type of cancer in the country. Basal cell carcinoma and squamous cell carcinoma are the most common forms of the disease. These types of cancers start in cells that are located in the outer layer of skin, which implies that invasive cutting surgical techniques are required to get […]
Non-Surgical Skin Cancer Treatment for Your Patients: The SRT-100™ to the Rescue
Your patients don’t enjoy being cut and surgeons don’t enjoy scarring them. Your patients value their time, as do medical practitioners. Your patients don’t like being in pain, and you don’t like causing them pain. Given all these premises, there is only one conclusion that we can arrive at. You need the SRT-100™ in your […]
Dr. Todd Plott of Dermatology Alliance Offers the SRT-100™
Dr. Todd Plott of Dermatology Alliance offers the SRT-100™ to his patients at his offices in Coppell and Keller, Texas. Watch the video below to hear all the reasons why Dr. Plott is excited to be able to provide his patients with Superficial Radiotherapy using the SRT-100™.
Alternative Skin Cancer Treatments Are Here! Your Answer: The SRT-100™
When compared to more conventional techniques, effective, alternative skin cancer treatments can be difficult to come by. At least they used to be difficult to come by, until the launch of the SRT-100™. This groundbreaking machine has a 95% cure rate for non-melanoma skin cancers, such as basal cell carcinoma and squamous cell carcinoma. The […]
Your Patients Now Have Access to Alternative Skin Cancer Treatments: The SRT-100™ Squashes Skin Cancer
We are willing to bet that as a physician, telling a patient they have been diagnosed with skin cancer can be one of the hardest pieces of information to deliver. What if we told you that three simple letters and a number could soften that blow tremendously? The SRT-100™ is that solution. This state of the […]
Suffering from Unsightly Keloid Scarring? The SRT-100™ is the Perfect Choice for Your Keloid Removal
No more surgery. No more cutting. No more pain. These are just some of the benefits of using the SRT-100™, among others, such as little downtime and no scarring. You may be asking yourself what the SRT-100™ is and what purpose it serves. The SRT-100™ is a piece of revolutionary machinery that has forever facilitated […]
The SRT-100™ is Revolutionizing Keloid Scar Treatment for Your Patients
Allow us to paint a scenario for you; a patient comes into your practice and seeks keloid treatment after removal. Imagine a process to reduce the chance of a recurrence of his or her scars following surgery without ever having to cut their skin, cause them pain, or touch more surgical tools. That solution you’re […]